announc fda approv micra av leadless dual-chamb
pacemak devic indic treatment patient av block impair
electr signal chamber heart approv opportun
materi increas micra tam increas av accord
compani expect full launch spring view clearli
superior technolog pacemak space leg competit
today estim expand indic allow take share
next year expens abbott uncov boston scientif given
opportun hand believ micra av could bolster top-lin growth cvg
divis bp entir entiti bp reiter ow
rate increas pt
cy ep
happen morn announc receiv fda approv
micra av back success clinic data marvel trial
present american heart associ novemb accord
compani begin train field personnel physician activ
limit number implant center come week full launch anticip
later spring
micra av vdd micra av vdd differ previou
gener micra vr treat patient need dual chamber pacemak
size shape previou version vdd indic provid dual
chamber sens av synchron ventricular pace devic mechan
acceleromet base atrial sens ventricl import
aspect devic abil expand elig marketplac micra vr
previou gener treat patient atrial fibril af atrioventricular
block hand micra av indic treatment patient
bit background atrioventricular block pace disord impact
electr signal atrium ventricl patient impact
signal ventricl may block sometim call heart block
base manag think believ micra av introduct expand
total address market patient today singl chamber
bradycardia market singl dual-chamb exhibit next
page inform continu next page
slowdown key market competit pressur regulatori delay
largest medic technolog compani global diversifi product offer
cardiolog surgeri spine neurolog diabet
piper sandler seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis report read conjunct import disclosur inform
includ attest regul analyst certif found page report follow site
page
micra indic expans outlin penetr elig market
sourc medtron websit investor day present
take overal signific impact much
beyond idea devic tripl address patient popul signific
moreov remain player market leadless singl dual-chamb
option provid signific runway sustain growth compani take market
share time anticip impact tradit dual-chamb pacemak player
abbott also offer tradit dual-chamb
pacemak doubt form cannib howev
cannib occur view like upgrad given higher asp
leadless devic breakdown opportun previou gener micra
vr address micra av expand allow
access address market pleas see exhibit estim domest
revenu opportun beyond conserv assum
realiz increment revenu opportun
page
stock thought reason highlight share close higher news
come surpris folk approv delay impact
good thing expect product consider impact
mdt top-lin long-term reiter ow rate increas pt
repres estim increas
target multipl base peer group multipl expans
page
million domest pacemak revenu opportunityaworldwid pacemak patient state percent patient tam pacemak contribut todaycassum asp leadless pacemak patient popul micra vr pacemak opportun revenu share vr micra vr contribut micra av contributionhaddress patient popul vr av micra vr av pacemak opportun increment micra av opportun revenu av increment revenu opportun increment domest revenu estim increment revenu achiev cvg medtron plc
million except per share data
good sold
percent sale
good sold
current disclosur inform compani locat http //www pipersandl com/researchdisclosur
